Quantification of adenosine A 2 A receptors in the human brain using [ 11 C ] TMSX and positron emission tomography
暂无分享,去创建一个
Kunihiro Chihara | Yoshitsugu Manabe | Yuichi Kimura | Keiichi Oda | Kiichi Ishiwata | Kenji Ishii | Mika Naganawa | Masahiro Mishina | K. Chihara | M. Mishina | Yoshitsugu Manabe | K. Ishii | K. Oda | Y. Kimura | K. Ishiwata | M. Naganawa | Y. Manabe
[1] M. Senda,et al. 11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligand. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] Y. Kimura,et al. Extraction of vessel-related information from PET images without continuous blood sampling using modified independent component analysis , 2001, 2001 Conference Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[3] J. Logan. Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.
[4] Yoshio Nakamura,et al. Greater adenosine A(2A) receptor densities in cardiac and skeletal muscle in endurance-trained men: a [11C]TMSX PET study. , 2005, Nuclear medicine and biology.
[5] B. Fredholm,et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.
[6] Yuichi Kimura,et al. Quantitative analysis of adenosine A1 receptors in human brain using positron emission tomography and [1-methyl-11C]8-dicyclopropylmethyl-1-methyl-3-propylxanthine. , 2004, Nuclear medicine and biology.
[7] Ayumu Matani,et al. Extraction of a plasma time-activity curve from dynamic brain PET images based on independent component analysis , 2005, IEEE Transactions on Biomedical Engineering.
[8] Yuichi Kimura,et al. Preclinical studies on [11C]TMSX for mapping adenosine A2A receptors by positron emission tomography , 2003, Annals of nuclear medicine.
[9] David J. Schlyer,et al. Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] T. Chase,et al. Adenosine A(2A) receptor antagonist treatment of Parkinson's disease. , 2003, Neurology.
[11] D E Kuhl,et al. Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] Ronald Boellaard,et al. Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] Tzvetelina Dimitrova,et al. Adenosine A2A receptor antagonist treatment of Parkinson’s disease , 2003, Neurology.
[14] Yuichi Kimura,et al. Potential of an adenosine A2A receptor antagonist [11C]TMSX for myocardial imaging by positron emission tomography: a first human study , 2003, Annals of nuclear medicine.
[15] B B Fredholm,et al. Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic study , 1997, Synapse.
[16] P. Svenningsson,et al. Adenosine–dopamine interactions , 2003, Neurology.
[17] Aapo Hyvärinen,et al. Fast and robust fixed-point algorithms for independent component analysis , 1999, IEEE Trans. Neural Networks.
[18] Pierre Comon,et al. Independent component analysis, A new concept? , 1994, Signal Process..
[19] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[20] Masanori Ichise,et al. Modeling of Receptor Ligand Data in PET and SPECT Imaging: A Review of Major Approaches , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[21] Kunihiro Chihara,et al. Omission of serial arterial blood sampling in neuroreceptor imaging with independent component analysis , 2005, NeuroImage.
[22] B. Fredholm,et al. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.
[23] W C Eckelman,et al. Kinetic Analysis of the 5-HT2A Ligand [11C]MDL 100,907 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] E. Ongini,et al. The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.
[25] M. Senda,et al. Further characterization of a CNS adenosine A2a receptor ligand [11C]KF18446 within vitro autoradiography andin vivo tissue uptake , 2000, Annals of nuclear medicine.
[26] Yuichi Kimura,et al. First visualization of adenosine A2A receptors in the human brain by positron emission tomography with [11C]TMSX , 2005, Synapse.
[27] Yoshio Nakamura,et al. Potential of [11C]TMSX for the evaluation of adenosine A2A receptors in the skeletal muscle by positron emission tomography. , 2004, Nuclear medicine and biology.